Market Overview

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Kite Pharma, Inc. to Gilead Sciences, Inc. is Fair to Shareholders


The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Kite Pharma, Inc. ("Kite
Pharma" or the "Company") (NASDAQ:KITE) stock prior
to August 28, 2017

You are hereby notified that Levi & Korsinsky, LLP has commenced
an investigation into the fairness of the sale
of Kite Pharma, Inc.
to Gilead Sciences, Inc. (NASDAQ:GILD). The
transaction is valued at approximately $11.9 billion. Under the terms of
the transaction, shareholders of Kite Pharma will receive $180.00 in
cash for each share of Kite Pharma common stock they own. To learn more
about the action and your rights, go to:

or contact Joseph E. Levi, Esq. either via email at or
by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you

Levi & Korsinsky is a national firm with offices in New York,
Connecticut, California, and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities lawsuits and have recovered hundreds of millions of
dollars for aggrieved shareholders
. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.

View Comments and Join the Discussion!
Fastest news service for the smartest traders
$147 Free 14 day Trial